MP48 - MP48: Urodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Neurogenic Voiding Dysfunction

Poster Presenter(s)

• 

  Aman Bali, MD

  Duke University School of Medicine
• 

  Ross Everett, MD,MPH

  Medical College of Wisconsin

  PDF Poster Slides and Audio
• 

  Reynaldo Gomez, MD

  Chief of Urology

  PDF Poster Slides and Audio
• 

  Reynaldo Gomez, MD

  Chief of Urology
• RG

  Ramy Goueli
• BG

  Baojun Gu
• MG

  Marilena Gubbiotti
• AH

  Ali Hashemi Gheinani
• EK

  Evgeniy Kreydin
• 

  Sara Lenherr, MD,MS

  University of Utah

  Poster
• AM

  Alexander Mackay, MD

  Houston Methodist Hospital

  PDF Poster Slides and Audio
• AM

  Anna Malykhina
• BP

  Benoit Peyronnet
• 

  Daniel Raza, BS

  Tulane University School of Medicine

  PDF Poster Slides and Audio
• 

  Wesley Smith, MD

  University of Texas Southwestern Medical School
• 

  KARTHIK TANNERU, MBBS MS

  nizams institute of medical sciences
• KT

  Katherine Theisen, MD

  University of Minnesota

  PDF Poster Slides and Audio
• BT

  Bogdan Toia
• AX

  Alison Xie

Presentations:

• 7:00 AM – 9:00 AM

  MP48-01: Pharmacogenetic inhibition of lumbosacral spinal and sensory neurons alleviates visceral pain and improves lower urinary tract symptoms in animal model of urological chronic pelvic pain syndrome
  Alison Xie
• 7:00 AM – 9:00 AM

  MP48-02: Urinary and Bowel dysfunctions and neuropsychiatric conditions in patients affected by Autism Spectrum Disorder
  Marilena Gubbiotti
• 7:00 AM – 9:00 AM

  MP48-03: The Effects of L-arginine on Urethral Function in Streptozotocin-induced and Insulin-treated Diabetic Rats
  Baojun Gu
• 7:00 AM – 9:00 AM

  MP48-04: Severity of Lower Urinary Tract Symptoms Associated with Diabetes Duration
  Aman Sarihyan Bali, MD
• 7:00 AM – 9:00 AM

  MP48-05: Multiomics-based Characterization of Bladder Remodeling After Spinal Cord Injury
  Ali Hashemi Gheinani
• 7:00 AM – 9:00 AM

  MP48-06: GENDER IMPACT ON BLADDER-RELATED OUTCOMES AND QUALITY OF LIFE AFTER PARAPLEGIC SPINAL CORD INJURY
  Sara M. Lenherr, MD,MS
• 7:00 AM – 9:00 AM

  MP48-07: FREQUENCY OF PATIENT-REPORTED UTIs PREDICTS POOR QUALITY OF LIFE AFTER SPINAL CORD INJURY
  Katherine M. Theisen, MD
• 7:00 AM – 9:00 AM

  MP48-08: Evaluation of Genitourinary Complications after Spinal Cord Injury: Results of Model Spinal Cord Injury Systems 15-year Follow-up Data
  KARTHIK TANNERU, MBBS MS
• 7:00 AM – 9:00 AM

  MP48-09: EXPERIENCE WITH SARS (SACRAL ANTERIOR ROOT STIMULATOR) IN SUPRASACRAL SPINAL CORD INJURY PATIENTS: LESSONS LEARNED
  Reynaldo Guillermo Gomez, MD
• 7:00 AM – 9:00 AM

  MP48-10: DETERMINANTS OF RECURRENT URINARY TRACT INFECTION IN SPINAL CORD INJURY PATIENTS
  Ross Everett, MD,MPH
• 7:00 AM – 9:00 AM

  MP48-11: Sacral neuromodulation with InterStim&[reg] for urinary voiding dysfunction in post-traumatic brain injury patients
  Reynaldo Guillermo Gomez, MD
• 7:00 AM – 9:00 AM

  MP48-12: The effect of stroke on micturition-related brain activity
  Evgeniy Kreydin
• 7:00 AM – 9:00 AM

  MP48-13: PROSPECTIVE EVALUATION OF INTRADETRUSOR INJECTIONS OF ONABOTULINUMTOXINA IN ADULTS WITH SPINAL DYSRAPHISM
  Alexander J. Mackay, MD
• 7:00 AM – 9:00 AM

  MP48-14: Urinary TIMP-2 and MMP-2 are significantly associated with poor bladder compliance in adult patients with spina bifida
  Benoit Peyronnet
• 7:00 AM – 9:00 AM

  MP48-15: Is there a role for surgical treatment in patients with Parkinson's disease and benign prostatic obstruction?
  Benoit Peyronnet
• 7:00 AM – 9:00 AM

  MP48-16: Comparative evaluation of white matter demyelination by magnetic resonance imaging and neurogenic voiding dysfunction in a viral murine model of multiple sclerosis
  Anna Malykhina
• 7:00 AM – 9:00 AM

  MP48-17: Alpha-1 Antagonist Treatment for Obstructive Urinary Symptoms in Patients with Multiple Sclerosis
  Daniel Raza, BS
• 7:00 AM – 9:00 AM

  MP48-18: Attrition rates and predictors of long-term (> 5 year) continuation of treatment with onabotulinumtoxinA intradetrusor injections
  Ramy Goueli
• 7:00 AM – 9:00 AM

  MP48-19: The efficacy of Onabotulinim toxin A in patients with augmentation cystoplasty
  Bogdan Toia
• 7:00 AM – 9:00 AM

  MP48-20: OUTCOMES OF PATIENTS WITH REFRACTORY OAB UNDERGOING PERCUTANEOUS TIBIAL NERVE STIMULATION IN REAL LIFE PRACTICE.
  Wesley James Smith, MD